Cocrystal Pharma, Inc. (COCP)
1.18
+0.01
(+0.85%)
USD |
NASDAQ |
Sep 15, 10:33
Cocrystal Pharma Price to Book Value : 15.59 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 15.45 |
| September 11, 2026 | 16.38 |
| September 10, 2026 | 16.25 |
| September 09, 2026 | 16.38 |
| September 08, 2026 | 15.59 |
| September 04, 2026 | 14.92 |
| September 03, 2026 | 14.92 |
| September 02, 2026 | 15.32 |
| September 01, 2026 | 14.79 |
| August 31, 2026 | 15.32 |
| August 28, 2026 | 14.53 |
| August 27, 2026 | 15.06 |
| August 26, 2026 | 14.79 |
| August 25, 2026 | 14.92 |
| August 24, 2026 | 14.66 |
| August 21, 2026 | 15.19 |
| August 20, 2026 | 15.45 |
| August 19, 2026 | 15.12 |
| August 18, 2026 | 14.26 |
| August 17, 2026 | 14.40 |
| August 14, 2026 | 14.79 |
| August 13, 2026 | 14.53 |
| August 12, 2026 | 14.79 |
| August 11, 2026 | 14.26 |
| August 10, 2026 | 14.26 |
| Date | Value |
|---|---|
| August 07, 2026 | 14.00 |
| August 06, 2026 | 13.60 |
| August 05, 2026 | 13.47 |
| August 04, 2026 | 12.95 |
| August 03, 2026 | 12.42 |
| July 31, 2026 | 10.83 |
| July 30, 2026 | 11.46 |
| July 29, 2026 | 11.49 |
| July 28, 2026 | 12.35 |
| July 27, 2026 | 12.13 |
| July 24, 2026 | 11.89 |
| July 23, 2026 | 12.15 |
| July 22, 2026 | 12.37 |
| July 21, 2026 | 12.28 |
| July 20, 2026 | 12.28 |
| July 17, 2026 | 12.55 |
| July 16, 2026 | 12.55 |
| July 15, 2026 | 12.68 |
| July 14, 2026 | 12.42 |
| July 13, 2026 | 12.68 |
| July 10, 2026 | 13.34 |
| July 09, 2026 | 13.34 |
| July 08, 2026 | 12.97 |
| July 07, 2026 | 13.47 |
| July 06, 2026 | 13.74 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.9490 |
| Fulcrum Therapeutics, Inc. | 0.9257 |
| Definium Therapeutics, Inc. | 5.524 |
Price to Book Value Related Metrics
| PS Ratio | 46.80 |
| Price | 1.18 |
| Earnings Yield | -64.30% |
| Market Cap | 16.27M |